Ardent Health Partners Inc (NYSE: ARDT)’s stock price has gone decline by -6.82 in comparison to its previous close of 19.06, however, the company has experienced a -7.02% decrease in its stock price over the last five trading days. businesswire.com reported 2024-09-18 that BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT) today announced it has entered into an amendment to its term loan credit agreement with its lenders to reprice its term loans. The repricing reduces the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 3.25% to Term SOFR plus 2.75%, as well as eliminates the credit spread adjustment. There are no changes to the maturity of the loans following the repricing and all other terms are subs.
Is It Worth Investing in Ardent Health Partners Inc (NYSE: ARDT) Right Now?
Analysts have mixed views on the stock, with 3 analysts rating it as a “buy,” 3 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ARDT is 23.23M, and currently, short sellers hold a 3.16% ratio of that float. The average trading volume of ARDT on October 04, 2024 was 505.54K shares.
ARDT’s Market Performance
The volatility ratio for the week is 6.33%, and the volatility levels for the last 30 days are 5.19% for Ardent Health Partners Inc (ARDT). The simple moving average for the past 20 days is -3.88% for ARDT’s stock, with a 0.23% simple moving average for the past 200 days.
Analysts’ Opinion of ARDT
Many brokerage firms have already submitted their reports for ARDT stocks, with Truist repeating the rating for ARDT by listing it as a “Buy.” The predicted price for ARDT in the upcoming period, according to Truist is $21 based on the research report published on August 12, 2024 of the current year 2024.
Stephens, on the other hand, stated in their research note that they expect to see ARDT reach a price target of $24. The rating they have provided for ARDT stocks is “Overweight” according to the report published on August 12th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to ARDT, setting the target price at $23 in the report published on August 12th of the current year.
ARDT Trading at -0.24% from the 50-Day Moving Average
After a stumble in the market that brought ARDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.51% of loss for the given period.
Volatility was left at 5.19%, however, over the last 30 days, the volatility rate increased by 6.33%, as shares sank -9.30% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.03% upper at present.
During the last 5 trading sessions, ARDT fell by -7.02%, in comparison to the 20-day moving average, which settled at $18.39. In addition, Ardent Health Partners Inc saw 10.59% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ARDT
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.98 for the gross margin
The net margin for Ardent Health Partners Inc stands at 0.02. The total capital return value is set at 0.05.
Based on Ardent Health Partners Inc (ARDT), the company’s capital structure generated 0.6 points at debt to capital in total, while cash flow to debt ratio is standing at 0.09. The debt to equity ratio resting at 1.48. The interest coverage ratio of the stock is 5.04.
Currently, EBITDA for the company is 370.35 million with net debt to EBITDA at 7.35. When we switch over and look at the enterprise to sales, we see a ratio of 1.53. The receivables turnover for the company is 3.87for trailing twelve months and the total asset turnover is 0.63. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.65.
Conclusion
To put it simply, Ardent Health Partners Inc (ARDT) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
